Involvement of αvβ 3 integrin and disruption of endothelial fibronectin network during the adhesion of the human ovarian adenocarcinoma cell line IGROV1 on the human umbilical vein cell extracellular matrix
Open Access
- 24 April 2002
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 99 (6), 800-808
- https://doi.org/10.1002/ijc.10433
Abstract
Like the majority of tumor cells, ovarian cancer cell growth is critically dependent on their neovascularization. Adhesion molecules and cellular events that lead to ovarian tumor cell interactions with endothelial extracellular matrix surrounding the vasculature are poorly identified. To understand the role of αvβ3 integrin and its ligand fibronectin in this process, we used in vitro coculture models with IGROV1 human ovarian adenocarcinoma cell line and human umbilical vein endothelial cells (HUVEC). Adhesion assays revealed a strong ability of IGROV1 cells to adhere to HUVEC‐ECM. αvβ3 is mainly implicated and seems to cooperate with α5β1 integrin in this event. Immunofluorescence staining revealed the presence of αvβ3 and α5β1 in IGROV1 cells adhering on HUVEC‐ECM at regions of cell sub‐stratum contacts. Furthermore, our data showed the absence of fibronectin staining in IGROV1 cells and the disruption of the HUVEC‐ECM fibrillar fibronectin network under IGROV1 cell influence. In situ experiments in ovarian neoplastic tissue corroborated the absence of fibronectin in the tumor and its strong detection in vasculature. These findings suggest the active participation of αvβ3 and α5β1 integrins and the reorganization of endothelial fibronectin during the adhesion of IGROV1 cells to HUVEC‐ECM whereas IGROV1 cells seem to be unable to synthesize fibronectin. Thus, fibronectin integrin receptors expressed by ovarian tumor cells and endothelial fibronectin may be of importance in ovarian carcinoma neovascularization and during tumor‐vasculature interactions.Funding Information
- Ligue de Lutte contre le Cancer (comité du Val d'Oise)
- University of Cergy-Pontoise
This publication has 23 references indexed in Scilit:
- Tumour vasculature as a target for anticancer therapyCancer Treatment Reviews, 2000
- Fibronectin and Its Integrin Receptors in CancerAdvances in Cancer Research, 1999
- Integrin signaling and cell growth controlCurrent Opinion in Cell Biology, 1998
- Tumor angiogenesis as a prognostic factor in ovarian carcinomaCancer, 1997
- Integrins and cancerCurrent Opinion in Cell Biology, 1996
- Cell adhesion molecules in angiogenesisCancer and Metastasis Reviews, 1996
- Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.JCI Insight, 1995
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vesselsCell, 1994
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992